- Potential Psychosis Induced by a Sustained High Plasma Levodopa Concentration Due to Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion in a Patient With Parkinson’s Disease: A Case Report
-
Toshiki Tezuka, Tomonori Nukariya, Yuta Kizuka, Shohei Okusa, Ryotaro Okochi, Yuto Sakai, Yoshihiro Nihei, Jin Nakahara, Morinobu Seki
-
J Mov Disord. 2024;17(4):453-455. Published online June 28, 2024
-
DOI: https://doi.org/10.14802/jmd.24114
-
-
1,869
View
-
184
Download
-
1
Web of Science
-
 PDF
- Levodopa Pharmacokinetics in Switching From Levodopa/Carbidopa Intestinal Gel to Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion in a Patient With Parkinson’s Disease: A Case Report
-
Tomonori Nukariya, Toshiki Tezuka, Shohei Okusa, Ryotaro Okochi, Yuto Sakai, Yoshihiro Nihei, Jin Nakahara, Morinobu Seki
-
Received November 28, 2024 Accepted January 6, 2025 Published online January 6, 2025
-
DOI: https://doi.org/10.14802/jmd.24247
[Epub ahead of print]
-
-
1,061
View
-
214
Download
-
1
Web of Science
-
1
Crossref
-
PDF
-
Citations
Citations to this article as recorded by  - Cognitive and Psychiatric Adverse Effects of Foslevodopa/Foscarbidopa in Patients with Parkinson's Disease
Sacha Brohée, Emmanuel Roze, David Grabli, Hélène Letrillart, Lise Mantisi, Cendrine Foucard, Elodie Hainque, Florence Cormier, Aurélie Méneret, Fabien Hauw
Movement Disorders Clinical Practice.2025;[Epub] CrossRef
|
KMDS
E-submission
